Search
for
Sort by
Research 691–720 of 1000+
- Androgen excess: Investigations and management
- Hair Loss in Women
- Intratesticular Control Of Steroidogenesis
- Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
- What causes hidradenitis suppurativa ?—15 years after
- Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- The hair growth promoting effect of Sophora flavescens extract and its molecular regulation
- 9 Pilosebaceous physiology in relation to hirsutism and acne
- Mechanistic target of rapamycin (mTOR) expression is increased in acne patients' skin
- Female Gonadal Function before and after Treatment of Acromegaly
- Ovarian Morphology Is a Marker of Heritable Biochemical Traits in Sisters with Polycystic Ovaries
- Effect of IGF-I on Hair Growth Is Related to the Anti-Apoptotic Effect of IGF-I and Up-Regulation of PDGF-A and PDGF-B
- PCOS in adolescents
- Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS
- Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes
- The SAHA Syndrome
- Polycystic ovary syndrome and impact on health
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- Pathways to inflammation: acne pathophysiology
- Role of Stearoyl-CoA Desaturase-1 in Skin Integrity and Whole Body Energy Balance
- Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism
- Medical treatment of hirsutism
- Role of Oxidative Stress in Polycystic Ovary Syndrome
- Familial Cortisol Resistance: Differential Diagnostic and Therapeutic Aspects
- Changes in the PCOS phenotype with age
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Ovarian Hypertension: Polycystic Ovary Syndrome
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research